End-to-End Clinical Trial & CRO Services in Switzerland
Comprehensive GxP Solutions Tailored for Switzerland’s Life Sciences Industry
Switzerland serves as a significant global center for pharmaceuticals and biotechnology, featuring a strong innovation ecosystem and stringent regulatory standards. Prominent life sciences companies and research entities operate under the oversight of Swissmedic, which ensures compliance with international regulatory frameworks like ICH and ICMRA. The nation’s practices align with ICH E6(R3) GCP and EU-GMP standards, ensuring quality, safety, and efficacy in clinical research and manufacturing.
Switzerland provides a favorable regulatory framework for clinical trial approvals, promoting innovation in advanced therapies and orphan drugs. Its strategic location in Europe and strong international reputation make it a crucial hub for global pharmaceutical development and commercialization.
Zenovel offers regulatory, quality, and scientific solutions for pharmaceutical, biotech, and healthcare companies to comply with Swissmedic regulations and thrive in Switzerland’s regulated life sciences market.
Good Clinical Practice (GCP) in Switzerland for Regulatory Compliance and Study Integrity
Building Trust in Clinical Research with GCP Compliance in Switzerland
Switzerland is a premier hub for clinical research, featuring advanced healthcare systems and skilled professionals while adhering to stringent regulatory standards. Zenovel provides specialized Good Clinical Practice (GCP) Contract Research Organization (CRO) services, ensuring the quality of clinical trials, participant safety, and compliance with regulations through thorough monitoring, GCP audit support, and risk-based quality management specific to the Swiss research landscape.
Our all-inclusive GCP services in Switzerland include the following:
- GCP consulting services: we enhance sponsor oversight, improve site compliance, and strengthen clinical quality management systems.
- Compliance with ICH-GCP guidelines and Swissmedic requirements is essential throughout the clinical trial lifecycle.
- Inspection readiness and sponsor oversight: Mock audits, documentation review, quality oversight, and site/vendor compliance support are essential for facilitating successful regulatory inspections.
- Regulatory consultancy: Regulatory intelligence, quality risk management, and operational excellence are essential for supporting efficient and compliant clinical development programs.
- Risk-based monitoring and quality oversight: To enhance data integrity, ensure patient safety, and improve trial performance.
Zenovel improves clinical trial quality in Switzerland through expert GCP services that enhance quality systems, ensure regulatory compliance, increase inspection readiness, and boost operational efficiency in clinical research programs.
Computer System Validation (CSV) Services in Switzerland for GCP & Data Integrity Compliance
Your Swiss Partner for Reliable Computer System Validation and Data Integrity
Validated computerized systems are critical for data integrity, patient safety, and regulatory compliance in clinical research. Zenovel provides thorough Computer System Validation (CSV) services in Switzerland, helping pharmaceutical, biotechnology, and healthcare organizations validate EDC systems, CTMS platforms, eTMF solutions, and safety databases. Our approach adheres to GAMP 5 principles, ICH-GCP requirements, Swissmedic expectations, and international GxP standards, ensuring effective operation throughout the system lifecycle.
Our tailored CSV services in Switzerland for clinical trials include:
- Validation planning and strategy development
- User requirements specification (URS) review and traceability management
- Risk assessments and computerized system risk classification
- Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) execution
- Audit trail verification and data integrity assessments
- Electronic records and electronic signatures compliance support
- Lifecycle documentation development and maintenance
- Change control, periodic review, and system retirement support
Through CSV compliance services in Switzerland, organizations can enhance electronic record integrity and quality assurance and reduce regulatory risks in clinical trials. Experts aid sponsors, CROs, and research institutions in establishing validated environments for reliable data and compliance. Zenovel ensures GCP-compliant system validation, focusing on data governance and readiness for inspections, satisfying Swissmedic and international regulations while maintaining efficient systems throughout the clinical trial process.
GCP Audit Services in Switzerland for Clinical Trial Quality Assurance
Precision Auditing for GCP-Compliant Clinical Research in Switzerland
Maintaining compliance is essential for clinical research success. Zenovel’s GCP audit services in Switzerland assist sponsors, CROs, and investigator sites in identifying compliance gaps and enhancing oversight. Our audits evaluate operations and documentation to ensure adherence to ICH-GCP standards and Swissmedic requirements, ensuring ethical and traceable clinical trials.
Our GCP Audit Services in Switzerland Include:
- Audit Services—investigator site audits, sponsor audits, vendor audits, and system-level quality assessments.
- Regulatory Alignment – compliance with ICH E6(R3) guidelines, Swissmedic regulations, and internationally recognized GCP standards.
- Key Compliance Assessments—protocol adherence, informed consent processes, source data verification, essential document review, documentation accuracy, and data integrity evaluations.
- CAPA & Inspection Readiness – CAPA development and management, risk-based quality improvement strategies, and inspection readiness planning for regulatory audits and inspections.
Organizations conducting clinical trials in Switzerland need reliable GCP auditing services to ensure compliance and maintain study quality. Zenovel’s auditors, with therapeutic expertise and regulatory knowledge, provide risk-based recommendations for continuous quality improvement. Our audit approach enhances governance, compliance, and risk mitigation, aiding preparation for Swissmedic and international inspections.
CRO Setup & Upgradation Services in Switzerland with GCP Compliance
Building Your Future-Ready Facilities Aligned with Swiss and Global GCP Standards
Switzerland is a premier hub for clinical research, bolstered by a strong healthcare ecosystem and stringent regulations. Establishing a CRO necessitates careful planning and compliance with Swissmedic and international standards.
Zenovel offers extensive services for CRO setup and enhancement, assisting sponsors and research organizations in establishing efficient, compliant, and inspection-ready clinical operations for high-quality trials.
New CRO Setup Services:
Our end-to-end CRO establishment services include the following:
- Clinical operations framework development
- Organizational structure design and governance planning
- Quality Management System (QMS) implementation
- Standard Operating Procedure (SOP) development and documentation systems
- Electronic systems selection and validation support (CTMS, eTMF, EDC, and safety databases)
- Risk-based monitoring framework implementation
- Vendor qualification and oversight processes
- Clinical trial quality and compliance program development
- Data integrity and GCP compliance framework establishment
- Staff training programs aligned with ICH-GCP and Swissmedic expectations
Existing CRO Upgradation Services
We offer tailored upgrade solutions focused on compliance, efficiency, and operational excellence.
- GCP gap assessments and remediation programs
- Quality system modernization and process optimization
- Sponsor oversight framework enhancement
- Risk-based quality management implementation
- Clinical monitoring process improvements
- Vendor management and governance optimization
- CAPA system strengthening and effectiveness reviews
- Inspection readiness and compliance improvement initiatives
- Data integrity and computerized system compliance assessments
- Alignment with Swissmedic requirements, ICH-GCP E6(R3), and international clinical research standards
Zenovel offers services to ensure continuous GCP compliance and prepare organizations for regulatory inspections and sponsor audits. Our services include inspection readiness assessments, mock inspections, document and TMF reviews, clinical trial evaluations, CAPA support, sponsor oversight, quality metrics monitoring, and regulatory strategy consulting.
With Switzerland’s strong position in the global life sciences sector, Zenovel ensures your CRO working modules remain compliant, inspection-ready, efficient, and competitive in international markets.
PK-Stat Review Services in Switzerland for Reliable Clinical Data Evaluation
Reliable PK-Stat Review for Robust Clinical Data Evaluation in Switzerland.
Accurate pharmacokinetic and statistical analyses are crucial for clinical development and regulatory submissions. Zenovel’s PK-Stat Review Services in Switzerland support pharmaceutical, biotechnology, and healthcare organizations in rigorously evaluating clinical data to ensure regulatory compliance and data reliability during the drug development process.
Our PK-Stat Review Services in Switzerland Include the Following:
- PK/PD Analysis – non-compartmental analysis (NCA), population pharmacokinetic modeling, exposure-response assessment, and dose-response evaluation.
- Regulatory Alignment—compliance with Swissmedic requirements, ICH guidelines, and international regulatory standards, including FDA and EMA expectations.
- Data Integrity & Statistical Review—comprehensive clinical biostatistics review, data quality assessment, statistical validation, and submission-ready outputs.
- Regulatory Support—independent PK and statistical review for bioequivalence studies, clinical trials, marketing authorization applications, and life cycle management submissions.
Our PK analysis services in Switzerland provide comprehensive evaluations, including bioavailability, dose proportionality, PK/PD interpretation, population modeling, and statistical reporting, adhering to global regulations. We assist sponsors in enhancing data quality and minimizing risks, fostering confidence in clinical decisions. Our PK-stat review services improve the reliability and regulatory readiness of clinical data, facilitating successful interactions with Swissmedic and international authorities.
Zenovel’s experts ensure that outputs are accurate, defensible, and ready for submission.
Pre-Inspection Readiness Services in Switzerland for GCP Compliance
Ensuring Flawless GCP Compliance Ahead of Every Inspection.
Regulatory inspections can affect clinical trial timelines and reputations. Zenovel provides pre-inspection readiness services in Switzerland for sponsors and CROs, focusing on GCP solutions. Our services assess trial documentation, operational processes, site performance, CAPA systems, and oversight frameworks to identify compliance gaps and enhance inspection readiness through effective remediation strategies.
Our Pre-Inspection Readiness Services in Switzerland Include:
- Gap assessments and mock inspections – Swissmedic-style simulated inspections designed to evaluate compliance and identify areas for improvement.
- Documentation reviews and quality system evaluations – assessment of informed consent processes, protocol adherence, essential documents, data integrity, vendor oversight, and quality management systems.
- CAPA effectiveness reviews and inspection response strategies – ensuring corrective and preventive actions are robust, sustainable, and inspection-ready.
- Staff training and inspection preparedness programs – equipping teams with the knowledge and confidence to manage inspections and respond effectively to regulatory inquiries.
Our clinical trial inspection readiness services in Switzerland ensure alignment with ICH-GCP guidelines and Swissmedic expectations, promoting regulatory compliance and operational transparency. By using our GCP inspection preparedness services, sponsors and CROs can improve audit readiness, reduce inspection findings, and enhance compliance management, ultimately fostering a proactive regulatory approach and successful inspections in clinical research.
Risk-Based Monitoring (RBM) Services in Switzerland for Efficient Clinical Oversight
Transitioning from On-Site to Data-Driven Monitoring with Zenovel
Zenovel’s Risk-Based Monitoring (RBM) services in Switzerland enhance clinical trials by implementing advanced, data-driven strategies. Our services focus on centralized and remote monitoring, critical data review, risk identification, and proactive quality management, aligning with ICH-GCP principles and Swiss regulatory standards.
- Centralized monitoring and the development of Key Risk Indicators (KRIs) are utilized to identify trends, anomalies, and potential compliance issues across various sites.
- Site risk assessments are critical for identifying potential vulnerabilities, while real-time data review strategies enhance proactive oversight and facilitate effective risk mitigation.
- Alignment with Swissmedic requirements and ICH E6(R3) guidelines for modern, risk-proportionate clinical trial management
- Transition from routine on-site monitoring to data-driven oversight, enabling more efficient allocation of monitoring resources.
- Remote monitoring and quality surveillance to enhance visibility into site performance and trial conduct.
Zenovel’s centralized monitoring services in Switzerland improve trial visibility and compliance, enabling early risk detection. We support sponsors, CROs, and research organizations in establishing scalable risk-based monitoring (RBM) frameworks, optimizing clinical quality and data integrity. Through advanced risk assessment and analytics, Zenovel enhances trial performance management and ensures inspection readiness throughout the clinical trial lifecycle.
Sponsor Oversight Services in Switzerland for Clinical Governance & Compliance
Mastering Swiss Clinical Trials Through Expert Sponsor Oversight
Effective sponsor oversight is needed for accountability, regulatory compliance, and quality in clinical development. Zenovel’s Sponsor Oversight Services in Switzerland assist sponsors in enhancing governance, controlling outsourced activities, managing vendors, monitoring site performance, tracking compliance metrics, and improving operational transparency throughout the clinical trial lifecycle.
Our Sponsor Oversight Services in Switzerland Include:
- CRO and Vendor Oversight – performance monitoring, vendor qualification, governance reviews, and ongoing compliance management.
- Clinical Trial Governance Frameworks—Risk-based oversight models are established and implemented to meet global regulatory expectations.
- Site Performance Monitoring – assessment of enrollment, protocol compliance, data quality, patient safety, and operational effectiveness.
- Quality and Compliance Oversight—audit trail reviews, CAPA management, quality metrics tracking, and inspection readiness support.
- Risk Assessment and Mitigation—proactive identification, evaluation, and management of operational and compliance risks throughout the study lifecycle.
- Regulatory Alignment – compliance with Swissmedic requirements, ICH E6(R3) guidelines, and international GCP standards.
Zenovel offers GCP-compliant sponsor oversight services in Switzerland that enhance clinical governance by aiding in risk assessments, quality system reviews, and vendor evaluations. By merging regulatory expertise with operational oversight, the services improve decision-making, maintain data integrity, and reduce operational risks in clinical trials, ensuring they meet regulatory and quality standards.
Good Manufacturing Practice (GMP) Services in Switzerland for Pharmaceutical Compliance
Supporting Swissmedic Compliance and Global Market Readiness
Maintaining high manufacturing standards is crucial for product quality, patient safety, and regulatory compliance in the pharmaceutical industry. Zenovel offers GMP services in Switzerland to assist pharmaceutical, biotechnology, and healthcare organizations in establishing and improving compliant manufacturing operations.
Our solutions span the manufacturing lifecycle, including quality system development, compliance assessments, inspection preparation, and continuous improvement, aligning with Swissmedic and global GMP requirements to enhance quality assurance and operational excellence.
- GMP audits evaluate and support the Quality Management System (QMS) by focusing on quality system assessment, enhancement, and continuous improvement in compliance.
- Deviation management, CAPA implementation, and documentation control are essential for strengthening quality processes and ensuring effective issue resolution.
- Inspection readiness programs encompass gap assessments, mock inspections, remediation planning, and support for regulatory preparedness.
- Process validation and compliance consulting focus on enhancing manufacturing processes while ensuring sustainable compliance with regulatory standards.
- Regulatory alignment involves ensuring compliance with Swissmedic requirements, as well as adherence to international quality standards (PIC/S GMP, EU-GMP, WHO GMP).
Zenovel’s GMP compliance services in Switzerland enhance documentation practices, quality oversight, CAPA effectiveness, and manufacturing controls. Utilizing a risk-based, quality-focused approach, the services aim to reduce compliance risks, improve operational efficiency, and ensure continuous inspection readiness.
We collaborate with manufacturers to create resilient quality systems that support regulatory compliance and facilitate successful inspections for access to Swiss and global markets.
GMP Audit Services in Switzerland for Manufacturing Quality Assurance
Strengthening Manufacturing Compliance Through Comprehensive GMP Audits
Uniform GMP audits are crucial for ensuring manufacturing quality and compliance with regulations. Zenovel offers GMP audit services in Switzerland for pharmaceutical, biotechnology, and healthcare manufacturers to evaluate their quality systems and processes against GMP standards.
Our approach identifies compliance gaps, assesses the effectiveness of quality systems, and provides recommendations for continuous improvement and readiness for inspections.
- Comprehensive GMP Audits involve a thorough evaluation of manufacturing facilities, QMS, production operations, documentation practices, batch records, change controls, and the effectiveness of CAPA.
- Supplier and internal audits focus on assessing vendor qualification programs, supplier quality systems, risk management processes, and internal compliance performance.
- Quality risk assessments involve identifying potential compliance vulnerabilities, conducting root-cause analysis, and recommending sustainable corrective actions.
- Inspection Readiness Support involves conducting gap assessments, mock regulatory inspections, audit coaching, and planning remediation to ensure preparedness for regulatory reviews.
- Documentation and Data Integrity Reviews include verification of GMP documentation practices, record accuracy, traceability, and compliance with data integrity principles.
- Regulatory Alignment audits are conducted in accordance with Swissmedic requirements, PIC/S GMP standards, EU-GMP guidelines, WHO GMP principles, and other applicable international regulations.
Zenovel’s GMP audit services enable organizations to identify operational weaknesses and enhance quality oversight ahead of regulatory inspections. Zenovel improves manufacturing systems by focusing on risk and compliance, which enhances product quality, operational efficiency, and readiness for regulations.
Our knowledge in GMP compliance and pharmaceutical quality supports independent audits that build confidence amid changing regulatory standards.
Pharma Plant Setup & Upgradation Services in Switzerland for GMP Compliance
Advancing Pharmaceutical Manufacturing Through Expert Facility Design, Expansion, and GMP Modernization
Establishing a pharmaceutical manufacturing facility in Switzerland necessitates strategic planning and regulatory compliance. Zenovel offers specialized services for Pharma Plant Setup & Upgradation, aiding companies in creating GMP-compliant facilities to enhance product quality and operational efficiency.
Our Pharma Plant Setup & Upgradation Services in Switzerland Include the Following:
- New Plant Setup—facility planning and design, cleanroom classification and qualification, HVAC system validation, equipment qualification (IQ/OQ/PQ), utility qualification, and QMS implementation.
- Existing Plant Upgradation – facility modernization, GMP gap remediation, contamination control improvements, manufacturing process optimization, capacity enhancement, and infrastructure upgrades.
- Regulatory Compliance Support—alignment with Swissmedic requirements, PIC/S GMP standards, EU-GMP guidelines, WHO GMP principles, and other applicable international regulations.
- Validation and Quality Integration – support for validation master planning, quality system strengthening, documentation development, and inspection preparedness.
Zenovel specializes in engineering and regulatory compliance to develop high-quality manufacturing facilities. We collaborate with organizations to improve operations, ensure GMP compliance, and implement sustainable practices.
Zenovel’s solutions enhance performance, mitigate regulatory risks, and ensure long-term success in pharmaceutical manufacturing, all while maintaining inspection readiness in line with Swiss and global standards.
Pre-Inspection Readiness Services for GMP Compliance in Switzerland
Achieving Inspection Confidence Through Proactive GMP Readiness
Regulatory inspections necessitate that pharmaceutical manufacturers exhibit strong quality systems and compliance documentation. Zenovel offers Pre-Inspection Readiness Services in Switzerland, assisting pharmaceutical and biotechnology companies in preparing for inspections by identifying compliance gaps and enhancing operational readiness.
Our Pre-Inspection Readiness Services for GMP Compliance in Switzerland Include:
- Comprehensive Gap Assessments—detailed evaluation of quality systems, manufacturing operations, documentation practices, validation programs, and compliance controls.
- Mock Regulatory Inspections—simulation of Swissmedic and international GMP inspections to assess organizational preparedness and identify areas requiring improvement.
- Audit Trail and CAPA Reviews—assessment of data integrity practices, audit trails, deviation management processes, and CAPA effectiveness.
- Documentation and Quality System Evaluation – review of SOPs, batch records, validation documents, training records, and quality management processes.
- Inspection Response Planning—development of structured inspection management strategies and regulatory communication plans.
- Compliance Training Programs – preparing personnel for inspector interactions, interview management, and real-time inspection response.
Zenovel offers GMP inspection readiness solutions that enable organizations to proactively tackle compliance issues, enhance quality oversight, and maintain continuous regulatory compliance.
By conducting risk-based assessments and employing targeted remediation strategies, Zenovel helps manufacturers minimize inspection findings and boost confidence during evaluations. Aligning operations with Swissmedic, PIC/S GMP, EU-GMP, and WHO GMP standards ensures sustained inspection readiness and supports product quality and operational excellence.
Clinical & Scientific Expert Services in Switzerland for Drug Development Programs
Transforming Scientific Innovation into Successful Clinical Development
Successful drug development necessitates scientific expertise, regulatory insight, and strategic planning. Zenovel offers Clinical & Scientific Expert Services in Switzerland, aiding pharma, biotech, and healthcare organizations across the product development lifecycle with specialized guidance in clinical strategy, protocol development, translational research, and evidence generation for compliant program development.
Our Clinical & Scientific Expert Services in Switzerland Include:
- Clinical Development Strategy and Protocol Design—development of scientifically robust clinical strategies aligned with Swissmedic requirements, ICH guidelines, and international regulatory expectations.
- PK/PD Modeling and Translational Science Support—integrating preclinical findings with clinical development plans to support informed decision-making and dose optimization.
- Biomarker Strategy, Endpoint Selection, and Study Optimization – enhancing study design quality, improving trial efficiency, and maximizing the likelihood of achieving development objectives.
- Therapeutic and Medical Consulting—expert input on disease areas, clinical relevance, benefit-risk evaluation, and development planning.
- Regulatory Scientific Consulting – strategic support for Swissmedic submissions as well as international regulatory interactions with agencies such as the FDA and EMA.
- Clinical Evidence Generation and Data Interpretation—supporting evidence-based development strategies and regulatory decision-making.
Our clinical and scientific consulting services enhance development programs through effective study design, scientific rationale, and regulatory alignment. Zenovel optimizes development pathways by combining therapeutic expertise with regulatory knowledge, helping sponsors mitigate risks and improve efficiency.
Our experts support various phases, providing strategic guidance to accelerate development timelines and increase the chances of regulatory and commercial success.
Medical & Scientific Writing Services in Switzerland for Regulatory Documentation
Supporting Regulatory Success Through High-Quality Medical and Scientific Writing
Clear and compliant documentation is essential for clinical development and regulatory submissions. Zenovel offers Medical & Scientific Writing Services in Switzerland to assist pharmaceutical, biotechnology, and healthcare organizations in creating robust, regulatory-compliant documents. Our experienced medical writers integrate scientific expertise and regulatory knowledge, ensuring adherence to Swissmedic, ICH guidelines, and international authorities while maintaining clarity and technical accuracy.
Our Medical & Scientific Writing Services in Switzerland Include:
- Clinical Study Reports (CSRs), Clinical Trial Protocols, and Investigator Brochures (IBs) – developed according to regulatory and industry standards.
- Informed Consent Forms (ICFs) and Patient-Facing Documents – ensuring clarity, ethical compliance, and participant understanding.
- CTD/eCTD Documentation Support—preparation and review of regulatory submission modules and supporting scientific documents.
- Pharmacovigilance and Safety Documentation—including safety narratives, risk management documentation, aggregate reports, and clinical summaries.
- Clinical and Regulatory Summaries – concise, scientifically accurate documents to support regulatory submissions and product development activities.
- Scientific Publications and Medical Communications—development of manuscripts, abstracts, posters, and scientific content for healthcare audiences.
Zenovel offers medical and scientific writing services to ensure document quality, scientific integrity, and regulatory compliance during clinical development. We align documentation with Swissmedic, ICH-GCP, ICH E3, and CTD/eCTD standards.
Our accurate, structured, audit-ready documentation enhances submission efficiency, aids regulatory review, and maintains traceability throughout the development lifecycle, transforming complex data into clear regulatory documents for successful strategies.
Preclinical Support Services in Switzerland for Early Drug Development
Transforming Scientific Innovation into Clinical Development Success
Robust preclinical research is vital for drug development. Zenovel offers Preclinical Support Services in Switzerland to assist pharmaceutical, biotechnology, and life sciences organizations in producing high-quality scientific evidence for informed decision-making before clinical development, thereby accelerating early-stage research while ensuring scientific rigor and regulatory compliance.
Our Preclinical Support Services in Switzerland Include:
- In Vitro and In Vivo Study Support – toxicology assessments, safety pharmacology studies, pharmacokinetic (PK) and pharmacodynamic (PD) evaluations, and nonclinical safety investigations.
- Bioanalytical and Translational Research Services – supporting the transition from discovery research to clinical development through scientifically driven translational strategies.
- Lead Candidate Optimization and Risk Assessment – evaluating compound characteristics, identifying potential development risks, and supporting candidate selection decisions.
- ADME and Drug Metabolism Support—absorption, distribution, metabolism, and excretion studies to strengthen understanding of candidate performance.
- Preclinical Development Strategy Consulting—scientific guidance for study planning, development pathways, and regulatory considerations.
- Regulatory Documentation Support – preparation and review of non-clinical documentation aligned with Swissmedic, ICH, FDA, and EMA expectations.
Zenovel provides preclinical support services aimed at generating reliable scientific data for regulatory submissions and development planning. Combining scientific expertise with regulatory knowledge, it helps organizations mitigate risks, enhance research efficiency, and strengthen clinical program foundations.
Our comprehensive solutions ensure preclinical programs meet scientific and regulatory requirements, facilitating a smoother transition to clinical research and future milestones.
Regulatory Affairs & Compliance Services in Switzerland for Global Approvals
Intensifying Product Approvals from Switzerland to Global Markets
Successfully entering international healthcare markets necessitates a clear regulatory strategy and compliance planning. Zenovel offers Regulatory Affairs Services in Switzerland, assisting pharmaceutical and biotechnology organizations in meeting Swiss and international regulations. Our experts develop approval strategies compliant with Swissmedic and global standards, ensuring timely market access and ongoing compliance throughout the product lifecycle.
Our Regulatory Affairs & Compliance Services in Switzerland Include the Following:
- Regulatory Strategy and Gap Analysis—customized regulatory roadmaps aligned with Swissmedic, FDA, EMA, ICH, and WHO requirements.
- CTD/eCTD Dossier Preparation and Management – support for IND/CTA submissions, marketing authorization applications, lifecycle maintenance, and regulatory variations.
- Labeling Compliance and Regulatory Intelligence—ensuring product information, labeling, and regulatory documentation remain compliant across multiple jurisdictions.
- Submission Planning and Coordination—managing submission timelines, document consistency, authority interactions, and regulatory correspondence.
- Lifecycle Regulatory Support – assistance with renewals, variations, change management, and post-approval compliance activities.
- Global Regulatory Consulting – strategic support for multinational development and registration programs.
Zenovel offers regulatory affairs and compliance services that minimize submission risks and enhance efficiency in interactions with health authorities. By leveraging local and global regulatory expertise, the team supports organizations through early development, marketing authorization, and post-approval activities, aiming to accelerate approvals and streamline processes for access to Swiss and international markets.
Dossier Due Diligence Services in Switzerland for Regulatory Submission Accuracy
Strengthening Regulatory Confidence Through Comprehensive Dossier Review
Successful regulatory submissions require accurate and complete documentation. Zenovel offers Dossier Due Diligence Services in Switzerland to assist pharmaceutical, biotechnology, and healthcare organizations in identifying submission risks before filing. Experts conduct comprehensive reviews of CTD and eCTD dossiers to ensure scientific consistency, regulatory compliance, and readiness, thereby minimizing the risk of delays and approval setbacks.
Our Dossier Due Diligence Services in Switzerland Include the Following:
- CTD/eCTD Gap Analysis—identification of missing information, inconsistencies, unsupported claims, formatting issues, and documentation deficiencies across submission modules.
- Clinical, Non-Clinical, and CMC Data Review—assessment of data consistency and alignment throughout the dossier to ensure a coherent scientific narrative.
- Regulatory Compliance Assessment – evaluation of dossier content against Swissmedic requirements, ICH guidelines, and applicable international regulatory standards.
- Module Integration and Submission Risk Evaluation—review of interdependencies between modules to identify potential regulatory concerns before submission.
- Quality and Traceability Assessment—verification of data integrity, document traceability, and supporting evidence throughout the dossier.
Zenovel’s dossier due diligence services assist organizations in identifying regulatory gaps, enhancing documentation, and improving submission strategies through thorough scientific and regulatory reviews.
Our support helps increase submission readiness, reduce regulatory risks, and improve the chances of efficient review and approval by Swissmedic and other health authorities.
eCTD Compilation Services in Switzerland for Global Regulatory Submissions
Building Regulatory-Compliant eCTD Dossiers for Global Market Access
As electronic submissions become mandatory, accurate eCTD compilation is vital for successful product registrations and lifecycle management. Zenovel offers eCTD Compilation Services in Switzerland to assist pharmaceutical, biotechnology, and healthcare companies in preparing compliant, submission-ready dossiers for regulatory authorities, including Swissmedic and ICH.
Our eCTD Compilation Services in Switzerland include:
- Document Formatting and Module Structuring—organization of regulatory documents according to CTD and eCTD specifications, ensuring consistency across all submission modules.
- Hyperlinking, Bookmarking, Validation, and Publishing – preparation of technically compliant dossiers that meet regulatory acceptance criteria and validation standards.
- CTD to eCTD Conversion—transformation of existing CTD dossiers into fully compliant eCTD submissions for regulatory filing.
- Lifecycle Management Support – management of sequences, variations, renewals, responses to regulatory queries, and post-approval submissions.
- Submission Quality Control Reviews—verification of dossier completeness, technical accuracy, formatting consistency, and submission readiness.
- Regulatory Alignment – compliance with Swissmedic requirements, ICH eCTD specifications, and internationally recognized electronic submission standards.
Zenovel’s regulatory eCTD services provide accurate and structured submissions to minimize rejection risks and delays. By offering dossier organization, quality control, and validation reviews, Zenovel enhances submission efficiency and accelerates approval timelines.
Our expertise in regulatory processes, combined with advanced publishing capabilities, supports organizations throughout the submission lifecycle, facilitating effective regulatory communication and successful market access.
Environmental Risk Assessment (ERA) Services in Switzerland for Pharmaceutical Compliance
Assisting Sustainable Pharmaceutical Development Through Environmental Risk Assessment Expertise
Environmental stewardship is essential in pharmaceutical development and compliance. Zenovel offers Environmental Risk Assessment (ERA) Services in Switzerland to assist organizations in evaluating and managing the environmental impact of their products. Our expertise aids in strengthening compliance and sustainability initiatives by assessing risks tied to pharmaceutical substances and manufacturing activities.
Our Environmental Risk Assessment Services in Switzerland Include the Following:
- Phase I and Phase II Environmental Risk Assessments—preliminary and detailed evaluations of potential environmental impacts associated with pharmaceutical products and manufacturing activities.
- PEC/PNEC Calculations and Exposure Modeling—estimation of Predicted Environmental Concentrations (PEC) and Predicted No-Effect Concentrations (PNEC) to support environmental risk characterization.
- Ecotoxicological Assessment and Data Evaluation—review and interpretation of ecotoxicity data to assess potential effects on aquatic and terrestrial ecosystems.
- Environmental Documentation and Regulatory Support—preparation and review of ERA reports and supporting documentation for regulatory submissions.
- Chemical Exposure and Environmental Impact Analysis—assessment of environmental exposure pathways, waste management considerations, and risk mitigation strategies.
- Global Regulatory Integration – support for environmental requirements associated with Swissmedic, EMA, FDA, WHO, and other international regulatory frameworks.
Zenovel provides pharmaceutical environmental risk assessment services to help organizations manage environmental risks across the product lifecycle. By combining scientific analysis with regulatory expertise, the company supports sustainable development strategies and regulatory compliance.
Our services include environmental assessments, risk mitigation planning, and documentation support, aimed at enhancing environmental governance and fostering commitment to sustainable operations in the pharmaceutical sector.
EU QP Support Services in Switzerland for Batch Release & GMP Compliance
Enabling Seamless European Market Access Through Expert EU QP Support
Zenovel offers EU QP Support Services in Switzerland to assist pharmaceutical manufacturers in complying with EU GMP requirements. These services include overseeing the batch release process, ensuring that quality systems, manufacturing records, and compliance documentation meet EU regulatory standards, and facilitating efficient batch certification for distribution in Europe.
Our EU QP Support Services in Switzerland Include the Following:
- Batch Record Review and GMP Compliance Verification—comprehensive assessment of manufacturing and quality documentation against EU GMP, PIC/S GMP, and applicable regulatory requirements.
- Deviation Assessment and Quality Review – evaluation of deviations, investigations, change controls, CAPA effectiveness, and product quality impacts.
- Qualified Person Coordination and Support—facilitating communication and documentation review processes required for QP certification and batch release.
- Quality Documentation Assessment – review of certificates, validation records, testing documentation, and batch-related quality data.
- Regulatory Compliance Verification – ensuring alignment with EU GMP Annex 16 requirements and international GMP expectations.
- Inspection Readiness and Quality Oversight—strengthening compliance frameworks to support successful regulatory inspections and audits.
Zenovel’s EU QP support services enhance batch traceability and quality assurance for pharmaceutical organizations, ensuring complete and compliant documentation prior to certification. By merging GMP expertise with regulatory knowledge, Zenovel minimizes export risks and ensures adherence to European quality standards. Our services align with Swissmedic, EU GMP, PIC/S GMP, WHO GMP, and EU Annex 16, facilitating efficient product release and access to European and international markets.
Regulatory Gap Analysis Services in Switzerland for Compliance Readiness
Turning Regulatory Challenges into Sustainable Compliance Success
Identifying regulatory and quality gaps before inspections or product approvals is crucial for compliance and avoiding delays. Zenovel offers Regulatory Gap Analysis Services in Switzerland for pharmaceutical, biotechnology, and healthcare organizations, aiding in the assessment of systems, processes, and documentation against regulatory expectations.
Experts conduct thorough evaluations across clinical, regulatory, quality, and manufacturing areas to identify vulnerabilities and provide strategies for remediation and continuous improvement.
Our Regulatory Gap Analysis Services in Switzerland Include the Following:
- Dossier Completeness and Data Integrity Reviews—assessment of clinical, non-clinical, and CMC documentation for consistency, traceability, and regulatory compliance.
- SOP and Quality System Assessments – evaluation of standard operating procedures, quality management systems, CAPA processes, change controls, and compliance frameworks.
- Submission Readiness Evaluations – review of regulatory submissions to ensure alignment with Swissmedic requirements and international submission standards.
- Gap Identification and Risk Assessment – detection of missing information, inconsistencies, unsupported claims, documentation deficiencies, and process weaknesses.
- Clinical and Manufacturing Compliance Reviews—assessment of operations against ICH-GCP, GMP, PIC/S, WHO, and other applicable regulatory requirements.
- Actionable Remediation Planning – prioritized recommendations and corrective action strategies designed to strengthen compliance and reduce regulatory risk.
Zenovel’s regulatory gap analysis services assist organizations in identifying compliance risks proactively. By conducting thorough assessments and implementing targeted remediation, Zenovel enhances documentation quality, operational efficiency, and regulatory compliance.
We align practices with standards from Swissmedic, ICH, PIC/S, EU-GMP, and WHO to strengthen quality systems and inspection readiness, promoting transparency and continuous compliance throughout the product lifecycle.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
